FinancingSeed money for unique topical hair growth inducerLatest NewsMallia Therapeutics GmbH has raised seed money to accelerate preclinical research and start Phase I testing of a baldness cure with unique MOA named soluble CD83. Read more 11 July 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Mallia-Update.jpg 1208 2374 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-07-11 10:18:252024-07-09 14:54:01Seed money for unique topical hair growth inducer